#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15380	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2103	726.6	0	.	n	.	0	C207T	SNP	207	207	C	448	448	T	818	T,C	560,174	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15380	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2103	726.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1425	1425	C	943	C,T	891,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27860	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3667	757.8	0	.	n	.	0	T695C	SNP	695	695	T	1066	1066	C	825	C	772	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27860	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3667	757.8	0	.	n	.	0	A1638G	SNP	1638	1638	A	2009	2009	G	850	G,A	796,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27860	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3667	757.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2342	2342	C	867	C,T	805,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27860	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3667	757.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2416	2416	A	863	A	807	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27860	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3667	757.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2968	2968	C	839	C,G	783,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2074	folP	855	855	100.0	folP.l15.c4.ctg.1	1561	132.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1020	1022	AGC	206;209;210	A;G;C	196;198;199	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5110	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3472	146.9	1	SNP	p	S91F	1	.	.	271	273	TTC	599	601	TTC	169;169;172	T;T;C	156;154;159	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5110	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3472	146.9	1	SNP	p	G95N	0	.	.	283	285	GGC	611	613	GGC	163;164;162	G;G;C	153;151;152	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5110	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3472	146.9	1	SNP	p	D95G	1	.	.	283	285	GGC	611	613	GGC	163;164;162	G;G;C	153;151;152	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1686	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1431	117.4	1	SNP	p	G45D	0	.	.	133	135	GGC	558	560	GGC	200;202;204	G;G;C	188;188;191	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	858	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1034	82.4	0	.	n	.	0	A197.	DEL	197	197	A	591	591	A	201	A	189	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5680	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2857	197.6	1	SNP	p	D86N	0	.	.	256	258	GAC	589	591	GAC	233;231;230	G;A;C	217;206;212	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5680	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2857	197.6	1	SNP	p	R87I	0	.	.	259	261	CGT	592	594	CGT	232;238;236	C;G;T	216;222;213	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5680	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2857	197.6	1	SNP	p	R87W	0	.	.	259	261	CGT	592	594	CGT	232;238;236	C;G;T	216;222;213	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5680	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2857	197.6	1	SNP	p	S87R	1	.	.	259	261	CGT	592	594	CGT	232;238;236	C;G;T	216;222;213	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5680	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2857	197.6	1	SNP	p	S88P	0	.	.	262	264	TCC	595	597	TCC	239;237;236	T,G;C;C	217,1;218;219	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4130	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2675	153.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1597	1599	GGC	199;198;199	G,T;G;C	189,1;189;186	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3908	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2319	167.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1194	1196	GCC	219;221;221	G;C;C	204;203;204	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3908	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2319	167.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1197	1199	ATG	222;223;218	A,C;T;G	205,1;206;197	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3908	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2319	167.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1209	1211	ACC	212;214;212	A;C;C	195;198;197	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3908	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2319	167.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1209	1211	ACC	212;214;212	A;C;C	195;198;197	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3908	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2319	167.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1710	1712	ACC	183;184;184	A;C;C	163;174;171	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3908	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2319	167.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1764	1766	GCG	164;162;162	G;C;G	157;154;156	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3908	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2319	167.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1764	1766	GCG	164;162;162	G;C;G	157;154;156	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3908	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2319	167.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1887	1889	GGT	166;164;163	G;G;T	147;148;146	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3908	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2319	167.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1896	1898	AGC	150;148;146	A;G;C	136;135;133	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3908	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2319	167.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1914	1916	CCG	121;122;121	C,G;C;G	103,4;105;104	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5930	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3128	189.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1674	1676	CCG	204;206;210	C;C;G	175;184;181	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2562	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1744	145.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	522	522	C	165	C	154	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	296	porB1a	984	286	91.03	porB1a.l6.c30.ctg.2	327	32.3	0	.	p	.	0	H217N	NONSYN	649	651	CAT	66	68	AAT	14;14;14	A;A;T	13;13;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	296	porB1a	984	286	91.03	porB1a.l6.c30.ctg.2	327	32.3	0	.	p	.	0	D218N	NONSYN	652	654	GAT	69	71	AAT	14;15;15	A;A;T	13;14;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	296	porB1a	984	286	91.03	porB1a.l6.c30.ctg.2	327	32.3	0	.	p	.	0	V226A	NONSYN	676	678	GTA	93	95	GCA	16;17;17	G;C;A	16;17;17	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	296	porB1a	984	286	91.03	porB1a.l6.c30.ctg.2	327	32.3	0	.	p	.	0	.	MULTIPLE	700	702	ACT	116	118	GTA	15;15;15	G;T;A	15;15;15	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	296	porB1a	984	286	91.03	porB1a.l6.c30.ctg.2	327	32.3	0	.	p	.	0	N237fs	FSHIFT	709	709	A	125	125	A	14	A	14	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2944	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1582	183.8	0	.	p	.	0	I45L	NONSYN	133	135	ATT	452	454	CTT	212;210;213	C;T;T	197;195;200	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2944	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1582	183.8	0	.	p	.	0	G210R	NONSYN	628	630	GGA	947	949	AGA	253;251;252	A;G;A	228;227;228	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2944	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1582	183.8	1	SNP	p	G120K	1	.	.	358	360	AAG	677	679	AAG	254;255;254	A;A;G,A	235;239;232,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2944	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1582	183.8	1	SNP	p	N121D	0	.	.	361	363	AAC	680	682	AAC	254;251;249	A;A;C	238;237;234	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2944	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1582	183.8	1	SNP	p	A121N	1	.	.	361	363	AAC	680	682	AAC	254;251;249	A;A;C	238;237;234	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11248	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4884	229.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1262	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1157	108.5	1	SNP	p	V57M	1	.	.	169	171	ATG	506	508	ATG	239;240;240	A;T;G,C	227;225;227,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
